cognitive neurotherapy & research
Neurasync has raised $3.3M in total funding. The most recent round was Seed. The last funding was announced in March 2023.
Neurasync's investors include Odegard Group.
Neurasync is headquartered in San Diego, United States.
cognitive neurotherapy & research
Neurasync is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neurasync — Funding & Investors." VCBacked, March 3, 2023, https://www.vcbacked.co/company/neurasync. Accessed August 13, 2026.
VCBacked. (2023). Neurasync — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/neurasync
{{cite web |title=Neurasync — Funding & Investors |url=https://www.vcbacked.co/company/neurasync |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated